Cellavita Executive Summary

​

​NestaCell®: A Breakthrough Therapy Offering Hope for ALS Patients

​

Advances in Cellular and Cell-Free Therapy Medicinal Products for
Huntington Disease Treatment

​

Brain-Derived Neurotrophic Factor and Stem Cell-Based
Technologies in Huntington’s Disease Therapy

​

Restoration of BDNF, DARPP32, and D2R Expression Following
Intravenous Infusion of Human Immature Dental Pulp Stem
Cells in Huntington’s Disease 3-NP Rat Model

​​

Unique Transcriptional Signatures Observed in Stem Cells from the Dental Pulp of Deciduous Teeth Produced on a Large Scale

 

​

​